Search Results - "Machulkin, A"

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Structure-activity relationship study of mesyl and busyl phosphoramidate antisense oligonucleotides for unaided and PSMA-mediated uptake into prostate cancer cells by Sergeeva, O, Akhmetova, E, Dukova, S, Beloglazkina, E, Uspenskaya, A, Machulkin, A, Stetsenko, D, Zatsepin, T

    Published in Frontiers in chemistry (04-03-2024)
    “…Phosphorothioate (PS) group is a key component of a majority of FDA approved oligonucleotide drugs that increase stability to nucleases whilst maintaining…”
    Get full text
    Journal Article
  2. 2

    Conjugates of Prostate-Specific Membrane Antigen Ligands with Antitumor Drugs by Uspenskaya, A. A., Machulkin, A. É., Mazhuga, A. G., Beloglazkina, E. K.

    Published in Pharmaceutical chemistry journal (15-07-2019)
    “…Conjugates for targeted delivery that are based on low-molecular-mass prostate specific membrane antigen (PSMA) inhibitors are widely used and developed…”
    Get full text
    Journal Article
  3. 3

    Nanohybride Materials Based on Magnetite-Gold Nanoparticles for Diagnostics of Prostate Cancer: Synthesis and In Vitro Testing by Machulkin, A. E., Garanina, A. S., Zhironkina, O. A., Beloglazkina, E. K., Zyk, N. V., Savchenko, A. G., Kotelyanskii, V. E., Mazhuga, A. G.

    “…We synthesized a fluorescence conjugate and modified magnetite-gold nanoparticles carrying prostate specific membrane antigen (PSMA) as the ligand. Analysis of…”
    Get full text
    Journal Article